Beta Bionics (BBNX) reported third-quarter 2026 net sales of $35.5 million, up 30% from $27.3 million a year earlier. The company recorded a net loss of $24.4 million, compared with a $14.2 million loss in the prior-year quarter.
The company updated full-year 2026 revenue guidance to approximately $124 million to $126 million, from prior guidance of $121 million to $126 million.
- DME channel net sales were $21.9 million, up 4% year over year.
- PBP channel net sales were $13.6 million, up 118% year over year.
- Gross margin was 57.3%, compared with 55.5% a year earlier.
- Cash, cash equivalents, and short- and long-term investments totaled $373.6 million as of September 30, 2026.
- Beta Bionics expects a full U.S. commercial launch of Mint in the first quarter of 2027.
$BBNX Insider Trading Activity
$BBNX insiders have traded $BBNX stock on the open market 27 times in the past 6 months. Of those trades, 0 have been purchases and 27 have been sales.
Here’s a breakdown of recent trading of $BBNX stock by insiders over the last 6 months:
- MARK HOPMAN (Chief Commercial Officer) has made 0 purchases and 9 sales selling 81,758 shares for an estimated $1,524,117.
- SEAN SAINT (President & CEO) has made 0 purchases and 3 sales selling 39,380 shares for an estimated $648,346.
- STEPHEN FEIDER (Chief Financial Officer) has made 0 purchases and 4 sales selling 23,351 shares for an estimated $382,132.
- CHRISTY JONES has made 0 purchases and 4 sales selling 12,645 shares for an estimated $228,214.
- MIKE MENSINGER (Chief Product Officer) has made 0 purchases and 3 sales selling 11,403 shares for an estimated $197,113.
- STEVEN JON RUSSELL (Chief Medical Officer) has made 0 purchases and 2 sales selling 8,443 shares for an estimated $133,903.
- ADAM LEZACK has made 0 purchases and 2 sales selling 1,998 shares for an estimated $21,137.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$BBNX Hedge Fund Activity
We have seen 81 institutional investors add shares of $BBNX stock to their portfolio, and 57 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DIVISADERO STREET CAPITAL MANAGEMENT, LP added 1,113,802 shares (+inf%) to their portfolio in Q2 2026, for an estimated $17,453,277
- JPMORGAN CHASE & CO added 703,356 shares (+inf%) to their portfolio in Q2 2026, for an estimated $11,021,588
- VESTAL POINT CAPITAL, LP removed 611,518 shares (-27.7%) from their portfolio in Q2 2026, for an estimated $9,582,487
- RTW INVESTMENTS, LP removed 500,000 shares (-25.0%) from their portfolio in Q2 2026, for an estimated $7,835,000
- TRI LOCUM PARTNERS LP added 493,344 shares (+inf%) to their portfolio in Q2 2026, for an estimated $7,730,700
- GOLDMAN SACHS GROUP INC added 415,771 shares (+342.7%) to their portfolio in Q2 2026, for an estimated $6,515,131
- BANK OF AMERICA CORP /DE/ added 410,435 shares (+301.3%) to their portfolio in Q2 2026, for an estimated $6,431,516
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
